Patents by Inventor Frederic Cachoux

Frederic Cachoux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED CYCLIC MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME
    Publication number: 20240174611
    Abstract: The present disclosure relates in part to chemical modulators of protein phosphatase 2A (PP2A). The compounds of the present disclosure are useful in treating, preventing, and/or ameliorating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease, abdominal aortic aneurysm, chronic liver disease, heart failure, neurodegenerative disease, and cardiac hypertrophy.
    Type: Application
    Filed: February 7, 2022
    Publication date: May 30, 2024
    Applicant: Rappta Therapeutics Oy
    Inventors: George L. Trainor, Maria Obdulia Rabal Gracia, Laura Fourmois, Olga Gherbovet, Frederic Cachoux
  • MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME
    Publication number: 20240174603
    Abstract: The present disclosure relates in part to chemical modulators of protein phosphatase 2A (PP2A), comprising formula (I). The compounds of the present disclosure are useful in treating, preventing, and/or ameliorating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease, abdominal aortic aneurysm, chronic liver disease, heart failure, neurodegenerative disease, and cardiac hypertrophy.
    Type: Application
    Filed: February 7, 2022
    Publication date: May 30, 2024
    Applicant: Rappta Therapeutics Oy
    Inventors: George L. Trainor, Maria Obdulia Rabal Gracia, Laura Fourmois, Olga Gherbovet, Frederic Cachoux
  • Derivatives of azaindazole or diazaindazole type for treating pain
    Patent number: 9381195
    Abstract: The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; for use in the treatment of pain.
    Type: Grant
    Filed: July 29, 2013
    Date of Patent: July 5, 2016
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Pierre Sokoloff, Frédéric Cachoux
  • DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE FOR TREATING PAIN
    Publication number: 20150190394
    Abstract: The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; for use in the treatment of pain.
    Type: Application
    Filed: July 29, 2013
    Publication date: July 9, 2015
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Pierre Sokoloff, Frédéric Cachoux